21st EDM Conference To Emphasize Fundamentals And Best Practices Of Document And Records Management
The Drug Information Association (DIA) will host the 21st Annual Electronic Document Management Conference: Managing Documents and Records , February 5-8, 2008, Philadelphia, PA. A special Regulatory Authority Day, featuring regulatory representatives, will focus on the need to produce regulatory-compliant electronic submissions.
"In the past, DIA's electronic document management programs have focused on the life science industry's move toward electronic information exchange and the wave of standards and initiatives to support this transformation," says Kay Bross, Program Co-chair and Senior PKI Specialist, Information Security and Solutions, Procter & Gamble Company. "This year's event will return to its grass roots and include the basics and best practices of document and records management."
Sessions will include introductory- through advanced-level topics and will address both technical and business issues of importance to large and small pharma in the US and global environments. The overall program will present a retrospective of the processes upstream and downstream of the regulatory submission process, content management from creation to archive, optimization, repurposing, and channeling information across the enterprise. Topics will include:
- Electronic Health Records
- Document/Records Management
- Content Reuse across the Common Technical Document
- How Recent Developments in CTD Content and Structured Content Affect Medical Writers
- Harmonization of Standards and Health Information Technology
- Managing Submissions with Partners
- Standards-Based Approach to Identity Management and Digital Signatures for Interoperability across the Pharmaceutical and Healthcare Sectors
- Metadata: The Future of Electronic Document Management
- Regulatory Compliance and Computerized Systems Validation
- Process Integration through EDMS Solutions
- eCTD Planning/Workflow
- Regulatory Updates
Janet Marchibroda, CEO, eHealth Initiative, will open the meeting with a keynote address, "High Quality Medical Care Costs Less: The Role of Standardization," describing the critical role that document management plays in the national Health IT efforts to improve patient healthcare.
Charles Jaffe, MD, PhD, Senior Global Strategist, Digital Healthcare, Intel Corporation, Former CEO, HL7, will then discuss activities related to data standards and why they are important for broad Health IT gains.
The event will also feature more than 30 exhibiting companies. For a complete list of exhibiting companies, go to www.diahome.org or contact Erin Gilliland at 215-442-6180 or Erin.Gilliland@diahome.org .
For meeting information, contact Joanne Wallace at 215-442-6180 or Joanne.Wallace@diahome.org . Media interested in attending the event or arranging for pre- or post-event interviews should contact Joe Krasowski at Joe.Krasowski@diahome.org or 215-293-5812.
About the Drug Information Association (DIA)
The Drug Information Association serves more than 18,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, Pa., USA, and with offices in Basel, Switzerland and Tokyo, Japan, the Association is led by its volunteer-based board of directors and executive management team. For more information, visit www.diahome.org .
SOURCE: Drug Information Association